Condition 101 content is not available at this time, but we are continually updating the site. Please check back.
However, there may be experts who have treated this or similar conditions in our Find a Doctor section and research may be available in our Latest Advances section.
Mark Sherrid is a Cardiologist in New York, New York. Sherrid has been practicing medicine for over 50 years and is rated as an Elite expert by MediFind in the treatment of Subvalvular Aortic Stenosis. He is also highly rated in 8 other conditions, according to our data. His top areas of expertise are Hypertrophic Cardiomyopathy (HCM), Cardiomyopathy, Familial Hypertrophic Cardiomyopathy, Subvalvular Aortic Stenosis, and Pacemaker Implantation. He is licensed to treat patients in New York. Sherrid is currently accepting new patients.
Martin Maron is a Cardiologist and a Radiologist in Morristown, New Jersey. Maron has been practicing medicine for over 24 years and is rated as an Elite expert by MediFind in the treatment of Subvalvular Aortic Stenosis. He is also highly rated in 20 other conditions, according to our data. His top areas of expertise are Hypertrophic Cardiomyopathy (HCM), Cardiomyopathy, Familial Hypertrophic Cardiomyopathy, Heart Transplant, and Transcatheter Aortic Valve Replacement (TAVR). He is licensed to treat patients in Massachusetts. Maron is currently accepting new patients.
Ethan Rowin is a Cardiologist in Morristown, New Jersey. Rowin has been practicing medicine for over 14 years and is rated as an Elite expert by MediFind in the treatment of Subvalvular Aortic Stenosis. He is also highly rated in 18 other conditions, according to our data. His top areas of expertise are Hypertrophic Cardiomyopathy (HCM), Cardiomyopathy, Familial Hypertrophic Cardiomyopathy, Heart Transplant, and Aortic Valve Replacement. He is licensed to treat patients in Massachusetts. Rowin is currently accepting new patients.
Summary: In this study, the investigators evaluated the association between various measures of adiposity [BMI and waist circumference (WC)] and clinical outcomes in Asian patients with hypertrophic cardiomyopathy, using a nationwide population based cohort.
Summary: This is a non-invasive/observational study in healthy and mild HF subjects utilizing clinical and ambulatory measurements to improve detection, monitoring, and management of HF risks.